Here in this article, we can get the coronavirus how the deadly Covid-19 outbreak from Wuhan city in China and spreading its tentacles across the world.
As the number of cases and deaths continue to increase daily, Pharmaceutical Technology surveyed readers on their view of how serious a threat Wuhan coronavirus is to global health.
Results from 1,803 respondents show significant concern about the seriousness of the threat this novel coronavirus poses with 35% seeing it as an extremely serious threat, 24% as a serious threat and 22% as a significant threat. This leaves just 19% seeing Wuhan coronavirus as a relative or very minor threat.
Poland reports first case
- Poland announced its first case of coronavirus. Almost 70 people were tested for the Covid-19.
- Gibraltar confirms its first case of coronavirus.
- Hungary confirmed its first two cases, both Iranian students.
The Wuhan coronavirus outbreak has been classed as an epidemic, which means it is a localized or regional outbreak – the two deaths that have occurred outside of China have been confined to Asia.
However, the continued spread of the virus across Europe and the Americas suggests that this could turn into a pandemic, defined as the worldwide spread of a new infectious disease.
It seems that the current epidemic meets all but one criteria of a pandemic, “community-level outbreaks”, where there is sustained human-to-human transmission of the disease in various parts of the world among people who have never traveled to China.
This is starting to happen in some parts of the world. In January, both Japan and Germany reported Wuhan coronavirus cases in people who had never traveled to China but were infected by people who had.
Corona virus Latest News
In a joint effort, the U.S. Food and Drug Administration and the Centers for Disease Control and Prevention took action to make more respirators, including certain N95s, available to health care personnel. Currently, the majority of respirators on the market are indicated for use in industrial settings. Today’s action allows certain National Institute for Occupational Safety and Health (NIOSH) approved respirators not currently regulated by the FDA to be used in a health care setting by health care personnel during the coronavirus (COVID-19) outbreak, thereby maximizing the number of respirators available to meet the needs of the U.S. health care system.